PAK1 and myxofibrosarcoma: In myxofibrosarcoma cell models, the constitutively hyperactive PAK1T423E significantly increased the PAK1 tyrosine phosphorylation and PF3758309 enabled concomitant inhibition on the phosphorylated threonine and tyrosine of PAK1.